Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HROW stock hub

Harrow, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HROWis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

HROW

In the news

Latest news · HROW

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E86.2

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-8.5

P25 -105.6P50 -46.5P75 -3.1

ROIC13.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HROW market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001360214
Company name	Harrow, Inc.
Country	United States
Country code	US
Cusip	415858109
Employees	373
Employees Change	-9%
Employees Change Percent	-2.36
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US4158581094
Last refreshed	2026-05-10
Market cap	$1.4B
Market cap category	Small-Cap
Price	$38.23
Price currency	USD
Rev Per Employee	730,034.85x
Sector	Healthcare
Sic	2834
Symbol	HROW
Website	https://www.harrow.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.36%
EV Sales Forward	4.47x
EV/EBIT	52.49x
EV/EBITDA	32.81x
EV/FCF	37.27x
EV/Sales	5.88x
FCF yield	3.02%
Forward P/E	86.23x
P/B ratio	27.14x
P/S ratio	5.23x
PS Forward	3.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.21%
EBITDA Margin	17.93%
FCF margin	15.78%
Gross margin	75.05%
Gross Profit	$204.4M
Gross Profit Growth	35.91%
Gross Profit Growth Q	34.02%
Gross Profit Growth3 Y	47.87%
Gross Profit Growth5 Y	42.81%
Net Income	$-5.1M
Net Income Growth Q	-2.23%
Net Income Growth Years	2%
Pretax Margin	-0.5%
Profit Margin	-1.89%
Profit Per Employee	$-13,777
ROA	4.84
Roa5y	2.06
ROCE	10.06
ROE	-8.47
Roe5y	-50.53
ROIC	13.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	26.31%
Cagr15y	14.84%
Cagr1y	55.52%
Cagr3y	12.15%
Cagr5y	36.16%
EPS Growth Q	-10.26
EPS Growth Years	2
OCF Growth3 Y	195.21%
Revenue Growth	36.42x
Revenue Growth Q	33.31x
Revenue Growth Quarters	22x
Revenue Growth Years	5x
Revenue Growth3 Y	45.39x
Revenue Growth5 Y	40.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.69
Assets	$399.5M
Cash	$75.1M
Current Assets	$211.8M
Current Liabilities	$96.3M
Debt	$252M
Debt EBITDA	$5.01
Debt Equity	$4.84
Debt FCF	$5.86
Equity	$52.1M
Interest Coverage	1.26
Liabilities	$347.4M
Long Term Assets	$187.7M
Long Term Liabilities	$251.1M
Net Cash	$-176.9M
Net Cash By Market Cap	$-12.42
Net Debt EBITDA	$3.62
Net Debt Equity	$3.4
Net Debt FCF	$4.12
Tangible Book Value	$-124.2M
Tangible Book Value Per Share	$-3.34
WACC	6.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.2
Inventory Turnover	5.61
Net Working Capital	$41.3M
Quick ratio	1.93
Working Capital	$115.4M
Working Capital Turnover	$2.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	933.24%
1Y total return	55.47%
200-day SMA	41.43
3Y total return	41.07%
50-day SMA	37.96
50-day SMA vs 200-day SMA	50under200
5Y total return	367.93%
All Time High	160
All Time High Change	-76.11%
All Time High Date	2009-10-06
All Time Low	0.5
All Time Low Change	7,546%
All Time Low Date	2012-03-16
ATR	1.71
Beta	0.34
Beta1y	2.82
Beta2y	2.29
Ch YTD	-21.98
High	39.29
High52	54.85
High52 Date	2026-01-07
High52ch	-30.3%
Low	38.05
Low52	21.12
Low52 Date	2025-05-09
Low52ch	81.01%
Ma50ch	0.71%
Premarket Change Percent	0.15
Premarket Price	$39.11
Premarket Volume	1,612
Price vs 200-day SMA	-7.72%
RSI	45.09
RSI Monthly	52.66
RSI Weekly	46.81
Sharpe ratio	0.97x
Sortino ratio	1.5
Total Return	-3.11%
Tr YTD	-21.98
Tr15y	696.46%
Tr1m	7.9%
Tr1w	-6.53%
Tr3m	-19.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$73.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.35
Earnings Revenue Estimate	52,055,144x
Earnings Revenue Estimate Growth	8.83x
Operating Income	$30.5M
Operating Income Growth	236.3
Operating Income Growth Q	18.54
Operating Income Growth3 Y	151.5
Operating Income Growth5 Y	110
Operating margin	11.21
Price target	$69.86
Price Target Change	$82.74
Price Target Change Top	$91.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,449,295%
Float Percent	73.64%
Net Borrowing	13,472,000
Shares Insiders	16.48%
Shares Institutions	50.41%
Shares Out	37,273,420
Shares Qo Q	0.26%
Shares Yo Y	3.11%
Short Float	23.34%
Short Ratio	12.4
Short Shares	17.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$30.5M
Average Volume	514,335.6x
Bv Per Share	1.41
CAPEX	$-887,000
Ch10y	933.2
Ch15y	696.5
Ch1m	7.9
Ch1w	-6.53
Ch1y	55.47
Ch3m	-19.21
Ch3y	41.07
Ch5y	367.9
Ch6m	12.67
Change	-2.1%
Change From Open	-2.1
Close	39.05
Days Gap	0
Depreciation Amortization	18,306,000
Dollar Volume	17,592,413.8
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$30.5M
EBITDA	$48.8M
EPS	$-0.14
F Score	5
FCF	$43M
FCF EV Yield	2.68x
FCF Per Share	$1.15
Financing CF	-12,724,000
Fiscal Year End	December
Founded	1,998
Goodwill	332,000
Income Tax	$3.8M
Investing CF	-5,460,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Last Split Date	2013-02-08
Last Split Type	Reverse
Last10k Filing Date	2026-03-02
Ma150	42.12
Ma150ch	-9.24%
Ma20	39.77
Ma20ch	-3.86%
Net CF	25,680,000
Next Earnings Date	2026-05-11
Open	39.05
Optionable	Yes
P FCF Ratio	33.16
P OCF Ratio	32.49
Position In Range	14.52
Post Close	38.23
Postmarket Change Percent	0.68
Postmarket Price	$38.49
Ppne	11,043,000
Pre Close	39.05
Price Date	2026-05-08
Price EBITDA	$29.19
Relative Volume	0.89x
Revenue	272,303,000x
SBC By Revenue	4.59x
Share Based Comp	12,502,000
Tax By Revenue	1.38x
Tr6m	12.67%
Us State	Tennessee
Volume	460,173
Z Score	2.89

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HROW pay a dividend?

Capital-return profile for this ticker.

Performance

HROW stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HROW?

Insider, institutional, and short-interest positioning.

Institutional ownership

+50.4%

Float: +73.6% of shares outstanding

Insider ownership

+16.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HROW momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.1

Neutral momentum band

Price vs 200-day MA

-7.7%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HROW

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HROW stock rating?

Harrow, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HROW analysis?

The full report lives at /stocks/HROW/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HROW?

The latest report frames HROW around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HROW page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.